tradingkey.logo

Edgewise Therapeutics Reports Positive Results On Sevasemten Program

ReutersJun 26, 2025 10:02 AM

- Edgewise Therapeutics Inc EWTX.O:

  • EDGEWISE THERAPEUTICS REPORTS POSITIVE RESULTS ON SEVASEMTEN PROGRAM FOR BECKER AND DUCHENNE MUSCULAR DYSTROPHIES

  • EDGEWISE THERAPEUTICS INC - TO MEET WITH FDA IN Q4 2025 TO DISCUSS PHASE 3 DESIGN

  • EDGEWISE THERAPEUTICS INC - NEW DATA SHOWS SUSTAINED DISEASE STABILIZATION IN BECKER UP TO THREE YEARS

  • EDGEWISE THERAPEUTICS INC - PHASE 2 OBSERVATIONS IN DUCHENNE DEFINE DOSE FOR PHASE 3

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI